E. Jägel-Guedes

HLA-B*5701 screening for hypersensitivity to abacavir.

S. Mallal, E. Phillips, J. Molina, 2008, The New England journal of medicine.

Seasonal variations in vitamin D levels in HIV-infected patients

E. Wolf, C. Spinner, E. Jägel-Guedes, 2017 .

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.

F. Tacke, B. Paulweber, M. Muche, 2022, Journal of hepatology.

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.

M. Manns, F. Baldanti, F. Ceccherini‐Silberstein, 2020, Journal of hepatology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study

E. Wolf, C. Spinner, E. Jägel-Guedes, 2017, Journal of the International Association of Providers of AIDS Care.

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

M. Muche, K. Gadow, D. Semela, 2024, JHEP Reports.